Sartorius Stedim Biotech S.A.

SRTOY | OTC

Price Alert Chart Builder DCF Calculator

$24.81

-$0.51 (-2.01%)

At close: Oct 30, 2026, 3:58 PM ET

$24.81

$0.00 (0.00%)

After-hours: Oct 30, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

-2.01%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

46.8

+11.4 pts

Fundamentals Average

Market Sentiment Neutral

Moat Narrow

Sector Rank #350/1028 (Top 34%)

Full Analysis

Key Statistics

Market Data

Market Cap $241.38B

1D Range

24.68 25.18

52W Range

17.70 26.54

Valuation (TTM)

PE 6.39

PB 48.67

EV/EBITDA 238.92

Valuation (NTM)

Forward PE N/A

Forward PEG 5.08

Price Target $0.00

Cash Flow

FCF Yield 0.1%

SBC Adj. FCF Yield 0.1%

SBC Impact N/A

Margins

Gross Margin 44.5%

Operating Margin 19.4%

FCF Margin 8.8%

Growth (CAGR)

Revenue 3Y | 5Y 1.1% | 3.0%

Dil EPS 3Y | 5Y -12.3% | -10.5%

FCF 3Y | 5Y 31.9% | -5.5%

Returns

ROA 4.0%

ROE 7.7%

ROIC 6.0%

Financial Health

Net Debt

€1.99B ($2.26B)

Current Ratio 1.22

Interest Coverage 3.78

Dividends

Div Yield 0.32%

Payout Ratio 2.5%

FCF Payout Ratio 24.9%

All Key Statistics

Loading financial charts...

Profile

Sartorius Stedim Biotech S.A. operates globally, providing essential instruments and consumables to the biopharmaceutical industry. Their product range is extensive, featuring items such as cell lines...

Sector Healthcare

Industry Medical - Instruments & Supplies

Employees 10,265

IPO Date Feb 9, 2022

Website www.sartorius.com

Fiscal Year n/a

Full Company Profile

Latest News

11 days ago · seekingalpha.com

Sartorius Stedim Biotech S.A. (SRTOY) Q3 2026 Earnings Call Transcript

3 months ago · seekingalpha.com

Sartorius Stedim Biotech S.A. (SRTOY) Q2 2026 Earnings Call Transcript